Search

Author/Creator Cruzalegui, Francisco

2. 315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody. (10th December 2020)

Authors:
Melero, Ignacio; Gomez-Roca, Carlos; Ferre, Pierre; Ferre, Pierre; Chetaille, Eric; Petain, Aurelie; Thuilliez, Celine; Vandenberghe, Isabelle; Cruzalegui, Francisco; Boudribila, Asmaa; Pavlyuk, Mariya; Marabelle, Aurelien
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A193
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody. (9th November 2020)

Authors:
Melero, Ignacio; Gomez-Roca, Carlos; Ferre, Pierre; Ferre, Pierre; Chetaille, Eric; Petain, Aurelie; Thuilliez, Celine; Vandenberghe, Isabelle; Cruzalegui, Francisco; Boudribila, Asmaa; Pavlyuk, Mariya; Marabelle, Aurelien
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A341
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. TIPIN depletion leads to apoptosis in breast cancer cells. Issue 8 (9th May 2015)

Authors:
Baldeyron, Céline; Brisson, Amélie; Tesson, Bruno; Némati, Fariba; Koundrioukoff, Stéphane; Saliba, Elie; De Koning, Leanne; Martel, Elise; Ye, Mengliang; Rigaill, Guillem; Meseure, Didier; Nicolas, André; Gentien, David; Decaudin, Didier; Debatisse, Michelle; Depil, Stéphane; Cruzalegui, Francis...
Journal:
Molecular oncology
Issue:
Volume 9:Issue 8(2015:Oct.)
Page Start:
1580
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗